Comments
Solara Active Pharma Sciences Ltd has announced that the USFDA has completed the inspection at its multipurpose API manufacturing facility in Visakhapatnam, Andhra Pradesh.
The inspection established that the site is in an “acceptable state of compliance” with zero form 483 inspectional observations.
The Visakhapatnam facility is a green field project spread over 40 acres and has facilities for the manufacture of Ibuprofen API.
Poorvank Purohit, MD & CEO said “This is the second US FDA inspection we have undergone at this site. We remain agile to the increasing requirements on quality and compliance, and I am confident that we will sustain our quality culture and anchor it further.”
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.